Product logins

Find logins to all Clarivate products below.


Biosurgical Agents | Market Insights | Latin America | 2021

Although it will be negatively impacted in the short term by the COVID-19 pandemic, the biosurgical agent market in Latin America will grow at a modest rate through 2029, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical outcomes, and the introduction of new products with enhanced features and expanded indications.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for biosurgical agents in the US across a 10-year period.

Related Medtech Insights Reports

Report
Gastrointestinal Endoscopy Devices – Market Insights – Latin America
The Latin American GI endoscopy devices market is projected to grow moderately through 2034, driven by ongoing innovation in both diagnostic and interventional applications of GI endoscopy…
Report
Gynecological Devices – Market Insights – Latin America
The Latin American gynecological device market will experience modest growth over the forecast period, driven primarily by increasing awareness of gynecological health and available treatment…
Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market is projected to experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative…
Report
Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…
Report
Interventional Cardiology Devices – Market Insights – Latin America
The Latin American IC device market will see strong growth over the forecast period, driven by a rising patient population, the introduction of next-generation devices, and the expanding adoption…